<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2
Image Overlay - Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron Awarded $450 Million to Manufacture REGN-COV2

July 15, 2020

Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron was awarded a $450 million contract through the U.S. government-funded Operation Warp Speed to manufacture and supply REGN-COV2. The COVID-19 antibody cocktail is currently in two Phase 2/3 clinical trials. As a leader in warehouse and inventory management, Yourway can provide the full scope of all biopharmaceutical storage and distribution needs, maximizing efficiency, and decreasing risk on any candidate.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?